Citron Research exposes Exact Sciences and PROVES beyond ANY doubt why this stock will soon be cut in half - so says a new reprot from Citron Research - Citron founder Andrew Left battled the CEO of Exact on CNBC on that topic for CNBC pro sub subscribers you can find that video here
UPDATE: 10:15AM EST May 16th 2017 - Exas CEO issued the following statement in response to Citron.
“Exact Sciences remains extremely confident in the near and long-term growth of Cologuard. We look forward to speaking with our valued investors both at the Bank of America Merrill Lynch conference tomorrow and during our second quarter earnings call.
“It should be noted that for years ‘research institutions’ have doubted...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
